Waterloo Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.74M Sell
23,463
-159
-0.7% -$37K 0.4% 62
2025
Q4
$4.89M Buy
23,622
+1,152
+5% +$228K 0.35% 65
2025
Q3
$4.17M Buy
22,470
+1,803
+9% +$309K 0.31% 78
2025
Q2
$3.16M Sell
20,667
-1,667
-7% -$256K 0.25% 96
2025
Q1
$3.7M Buy
22,334
+6,236
+39% +$976K 0.34% 78
2024
Q4
$2.33M Buy
16,098
+1,681
+12% +$260K 0.25% 98
2024
Q3
$2.34M Buy
14,417
+10,229
+244% +$1.63M 0.26% 99
2024
Q2
$612K Sell
4,188
-4,104
-49% -$610K 0.07% 197
2024
Q1
$1.31M Buy
8,292
+1,486
+22% +$237K 0.17% 124
2023
Q4
$1.07M Buy
6,806
+4,279
+169% +$656K 0.17% 131
2023
Q3
$394K Buy
2,527
+149
+6% +$24.6K 0.12% 120
2023
Q2
$394K Sell
2,378
-46
-2% -$7.42K 0.12% 110
2023
Q1
$376K Buy
+2,424
New +$391K 0.12% 111
2020
Q1
$289K Buy
+2,200
New +$312K 0.21% 107

Other funds holding JNJ

Waterloo Capital's JNJ Position: Q1 2026 in Review

Waterloo Capital reduced its Johnson & Johnson (JNJ) stake by 0.67% in Q1 2026, selling an estimated $37K and leaving 23,463 shares worth $5.74M. The position accounts for 0.4% of the portfolio, ranked #62.

Waterloo Capital first reported a position in JNJ in Q1 2020 and has held it in 14 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Waterloo Capital held 23,463 shares of Johnson & Johnson worth $5.74M as of Q1 2026.
  • Waterloo Capital sold 159 Johnson & Johnson shares in Q1 2026, an estimated $37K.
  • Johnson & Johnson made up 0.4% of Waterloo Capital's portfolio in Q1 2026, its #62 holding.
  • Waterloo Capital first reported a position in Johnson & Johnson in Q1 2020 and has held it in 14 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Waterloo Capital's 13F filing for Q1 2026, filed 12 May 2026.